CClinicalTrials.gg
CompletedNCT07344272Updated Sep 4, 2026

The Effects of Proprioceptive Neuromuscular Facilitation

An interventional study of Proprioceptive neuromuscular facilitation in Scapular Winging, sponsored by Manisa Celal Bayar University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-09-04.

Sponsored by Manisa Celal Bayar University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Study summary

This study aims to investigate the effects of proprioceptive neuromuscular facilitation (PNF) on shoulder girdle function and quality of life in individuals with scapular winging.

Read the detailed description

Scapular stability on the thorax is fundamental for maintaining proper upper extremity function. The loss of this stability manifests clinically as scapular winging, a pathological condition characterized by the prominent protrusion of the medial (vertebral) border and/or the inferior angle of the scapula away from the thorax.

PNF can target the underlying impairment of scapular dysfunction by activating the muscle synergies required for scapulothoracic stability more powerfully and coordinately through resisted diagonal movements.

Therefore, the implementation and testing of PNF protocols are of critical importance, as this method can enhance functional strength and coordination, contributing to better clinical outcomes and improved quality of life in individuals with scapular winging.

Therefore, this study aims to investigate the effects of PNF on shoulder girdle function and quality of life in individuals with scapular winging.

In this study, designed as a randomized controlled trial, one group will receive PNF in scapular diagonals for approximately 20-30 minutes, three days a week, for a total of five weeks, to ensure scapular positioning and increase the tone of the surrounding muscles.

The control group will receive no intervention during this period.

Before (pre-test) and after (post-test) the study, participants in both groups will be evaluated using the Scapular Isometric Pinch Test for scapular muscle endurance; the Lateral Scapular Slide Test for scapular position; the Rounded Shoulder Posture Assessment for shoulder posture; the Disabilities of the Arm, Shoulder, and Hand Questionnaire for upper extremity functional level; and the Short Form-36 for quality of life.

02

Conditions studied

  • Scapular Winging

Keywords

  • Functional status
  • Neuromuscular effect
  • Proprioceptive neuromuscular facilitation
  • Quality of life
  • Scapula
03

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Volunteering to participate in the study.
  • Presenting with bilateral scapular winging (Scapular winging will be evaluated by measuring the distance between the inferior angle of the scapula and the thoracic wall using a scapulometer; a distance of ≥2 cm is considered as winging).

Exclusion criteria

Exclusion Criteria:

  • Presence of long thoracic nerve palsy.
  • Having undergone shoulder surgery within the last 12 months or having an acute shoulder injury (e.g., rotator cuff tear, dislocation, labral pathology, etc.).
  • Presence of scapulothoracic bursitis, fractures, tumors, or structural deformities in the scapular/thoracic region.
  • Having received regular scapular or shoulder rehabilitation within the last 6 months.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Active comparator
    Proprioceptive Neuromuscular Facilitation Group

    The Proprioceptive Neuromuscular Facilitation Group will receive proprioceptive neuromuscular facilitation for a duration of 5 weeks, scheduled three times per week, with a session length of approximately 20-30 minutes.

    Other: Proprioceptive neuromuscular facilitation

  • No intervention
    Control Group

    The Control Group will receive no intervention.

Interventions

  • OtherProprioceptive neuromuscular facilitation

    The Proprioceptive Neuromuscular Facilitation Group will receive proprioceptive neuromuscular facilitation for a duration of 5 weeks, scheduled three times per week, with a session length of approximately 20-30 minutes.

05

What researchers measure

Primary outcomes

  1. Biodex System 3 Pro

    Isokinetic strength measurement of the shoulder girdle muscles will be performed using a Biodex System 3 Pro isokinetic dynamometer. The measurements will be conducted in a diagonal plane specifically determined to align with scapular patterns, utilizing a concentric-concentric mode at two different angular velocities: 60°/s and 180°/s. For each test, participants will perform three trial sets; the peak torque values obtained from each set will be normalized to body weight (Nm/kg) and averaged for statistical analysis. During the test protocol, participants will be securely positioned using stabilization straps to ensure arm and trunk stability. Prior to the measurements, a device orientation and warm-up session (e.g., three practice/familiarization sets) will be conducted, followed by the actual data collection.

    Time frame: one week

Secondary outcomes

  1. Scapular Isometric Pinch Test

    The scapular stabilizer muscles' endurance will be evaluated using the Scapular Isometric Pinch Test. During the test, participants will be asked to maintain the scapula in a bilateral retraction position and will be verbally encouraged to sustain the position for as long as they can maintain a maximal isometric contraction. The endurance time will be recorded in seconds.

    Time frame: one week

  2. The Lateral Scapular Slide Test

    The Lateral Scapular Slide Test will be used to evaluate scapular dyskinesis. During the test, the participant will be positioned with their back to the researcher. The assessment will be performed bilaterally in three different upper extremity positions: i) 0° of abduction with the arms in a neutral position, (ii) 45° of abduction with the hands placed on the hips and the thumbs pointing posteriorly, and (iii) 90° of abduction with the shoulders parallel to the floor and the arms held in maximum internal rotation. In all three positions, the scapular position will be determined by measuring the distance between the inferior angle of the scapula and the spinous processes of the thoracic vertebrae.

    Time frame: one week

  3. Disabilities of the Arm, Shoulder, and Hand Questionnaire

    The functional status of the upper extremity will be evaluated using the Disabilities of the Arm, Shoulder, and Hand Questionnaire. The Disabilities of the Arm, Shoulder, and Hand Questionnaireis a 30-item self-report scale that measures activities of daily living, symptom severity, and social/role functioning related to the upper extremity. Participants rate each item on a scale from 1 (no difficulty/no symptom) to 5 (unable to do/severe symptoms). The total score is transformed into a 0-100 range based on the item averages; higher scores indicate greater functional impairment.

    Time frame: one week

  4. Short Form-36

    Quality of life will be evaluated using the Short Form-36. The Short Form-36 assesses eight distinct health domains categorized under two main component summaries: Physical Functioning, Role Limitations due to Physical Problems, Bodily Pain, General Health Perceptions, Vitality, Social Functioning, Role Limitations due to Emotional Problems, and Mental Health. The scale scores range from 0 (worst health status) to 100 (best health status), with higher scores indicating a better quality of life.

    Time frame: one week

06

Study locations

1 site
  • Manisa Celal Bayar University
    Manisa, Turkey (Türkiye)
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07344272
Lead sponsor
Manisa Celal Bayar University
Responsible party
Erhan Seçer (Lecturer, PT., PhD., Manisa Celal Bayar University) — Principal investigator
First posted
Jan 15, 2026
Start date
Feb 1, 2026
Primary completion
Mar 8, 2026
Completion
Mar 15, 2026
Last update
Sep 4, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion